Most current models of T cell activation postulate a requirement for two distinct signals. One signal is delivered through the TCR by engagement with peptide/MHC complexes, and the second is delivered by interaction between costimulatory molecules such as CD28 and its ligands CD80 and CD86, Soluble peptide/MHC tetramers provide an opportunity to test whether naive CD8(+) T cells can be activated via the signal generated through the TCR-alpha beta in the absence of any. potential costimulatory molecules. Using T cells from two different TCR transgenic mice in vitro, we find that TCR engagement by peptide/MHC tetramers is sufficient for the activation of naive CD8(+) T cells. Furthermore, these T cells proliferate, produce cytokines, and differentiate into cytolytic effecters. Under the conditions where anti-CD28 is able to enhance proliferation of normal B6 CD4(+), CD8(+), and TCR transgenic CD8(+) T cells with anti-CD3, we see no effect of anti-CD28 on proliferation induced by tetramers, The results of this experiment argue that given a strong signal delivered through the TCR by an authentic ligand, no costimulation is required.